FRESH-PEF3626-en
Inter-cohort and clinical centers collaboration of subjects co-infected by human immunodeficiency virus and hepatitis C
ANRS C013 HEPAVIH
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Participant-reported health data','Biological data','Paraclinical data (non-biological) : Imaging']
Individuals
| Topic | Vocabulary |
|---|---|
| Clinical immunology | health theme |
| Infectious disease medicine | health theme |
| HIV disease clinical stage 2 without mention of tuberculosis or malaria | cim-11 |
| Viral hepatitis | cim-11 |
| Behavioral determinants | health determinant |
{
"level_sex_clusion_I": [
{
"value": "Male",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008297"
}
},
{
"value": "Female",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D005260"
}
},
{
"value": "Other",
"concept": {
"vocab": [],
"vocabURI": []
}
}
],
"level_age_clusion_I": [
{
"value": "Young Adult (19 to 24 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D055815"
}
},
{
"value": "Adult (25 to 44 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000328"
}
},
{
"value": "Middle Aged (45 to 64 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D008875"
}
},
{
"value": "Aged (65 to 79 years)",
"concept": {
"vocab": "MeSH",
"vocabURI": "http:\/\/id.nlm.nih.gov\/mesh\/D000368"
}
}
],
"level_type_clusion_I": [
"Patients population"
],
"level_type_clusion_other": "",
"clusion_I": "Adults infected by HIV virus carriers of VHC or cured after anti-VHC treatment, or spontaneously healed without anti-VHC treatment or benefiting from an anti-VHC tritherapies.",
"clusion_E": ""
}
| Name |
|---|
| Laure;ESTERLE |
| Dominique;SALMON |
| Philippe;SOGNI |
| Name | Role |
|---|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) | sponsor |
| Name |
|---|
| AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE) |
| F. HOFFMANN-LA ROCHE AG |
| GLAXOSMITHKLINE (FRANCE) |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
| JANSSEN CILAG (JANSSEN - JOHNSON & JOHNSON - JOHNSON & JOHNSON INNOVATIVE MEDICINE) |
| MERCK SANTE |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2005-01-01 | 2018-01-01 |
| Standard |
|---|
| ['---'] |
['Data utilization possible for academic teams and for industrials. Temporary access condition : project accepted by the scientific committee']
Data utilization possible for academic teams and for industrials. Temporary access condition : project accepted by the scientific committee
{"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
Temporary access condition : project accepted by the scientific committee
| Name | |
|---|---|
| Linda;WITTKOP | linda.wittkop@u-bordeaux.fr |
| Dominique;SALMON | dominique.salmon@aphp.fr |
| Philippe;SOGNI | philippe.sogni@aphp.fr |
FRESH-PEF3626-en
| Name | Affiliation |
|---|---|
| Laure ESTERLE | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |